US Stock Market Move | Affirm Holdings (AFRM.US) rose more than 6%, with the stock price reaching its highest level in 52 weeks at one point.
As of the time of writing, the stock has risen by more than 6%, reaching $59.67.
On Monday, Affirm Holdings (AFRM.US) stock price briefly touched a 52-week high, and as of the time of writing, the stock is up over 6% at $59.67. Mizuho raised their price target on the stock from $65 to $69.
Related Articles
On March 9th, S.F. Holding (06936) spent 67.5943 million yuan to repurchase 1.8297 million shares of A shares.
HBM HOLDINGS-B (02142): HBM7575, a new drug for the treatment of atopic dermatitis, has received approval for clinical trial application from the NMPA.
HENLIUS(02696): HLX3901 injection (DLL3xDLL3xCD3xCD28 tetra-specific antibody) clinical trial application for late-stage/metastatic solid tumor patients approved by the National Medical Products Administration.
On March 9th, S.F. Holding (06936) spent 67.5943 million yuan to repurchase 1.8297 million shares of A shares.
HBM HOLDINGS-B (02142): HBM7575, a new drug for the treatment of atopic dermatitis, has received approval for clinical trial application from the NMPA.
HENLIUS(02696): HLX3901 injection (DLL3xDLL3xCD3xCD28 tetra-specific antibody) clinical trial application for late-stage/metastatic solid tumor patients approved by the National Medical Products Administration.
RECOMMEND
